1.
Efficacy and Safety of Ruxolitinib Cream by Anatomic Region in Children Aged 2 to 11 Years With Atopic Dermatitis: Results From TRuE-AD3. J of Skin [Internet]. 2024 Nov. 18 [cited 2025 Jul. 3];8(6):s453. Available from: https://skin.dermsquared.com/skin/article/view/3070